Abcam Hong Kong

Abcam Hong Kong is owned by Abcam.

Abcam is one of the...

• Russell 3000.

Abcam is a company listed under the stock ticker ABC (GB).

Abcam has a direct presence in 2 countries.

Acquisition, funding and merger involving Abcam.

• Abcam has announced the acquisition of Danaher  (posted on August 30 2023).

View the org chart displaying its 2 main executives

Most searched biographies at Abcam Hong Kong

• Chan Emma, General Manager
• Anna Szeto, Marketing Director

Create your alert
to follow the executive moves at Abcam Hong Kong.

Abcam has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Abcam Hong Kong

Social media about Abcam Hong Kong

• Abcam Hong Kong on Wikipedia, Google News & Yahoo Finance
• Abcam Hong Kong on LinkedIn, Twitter & YouTube

Call Abcam Hong Kong at +852 ...

View the org chart

Register to receive your alert

Report an error